DRGT Completes a Pivotal Phase I Trial; Results Confirm 6X Faster Attainment Of Maximum Plasma Levels For Pain Management Compared To Currently Available COX-2 Inhibitor
June 10, 2019 09:00 ET
|
Druggability Technologies Holdings Ltd
BUDAPEST, Hungary, June 10, 2019 (GLOBE NEWSWIRE) -- Druggability Technologies Holdings (DRGT) today announced results from a pharmacokinetic study of their novel formulation of celecoxib...
Perluxan Proven Safer Option for Pain Relief
February 13, 2014 14:26 ET
|
Perluxan
KEARNY, NJ--(Marketwired - Feb 13, 2014) - The slippery slope for pain relief frequently starts in pharmacy aisles with over-the-counter NSAIDs (non-steroidal anti-inflammatory drugs), such as...